The burgeoning popularity of tirzepatide , initially for metabolic conditions, is creating significant interest within the United Kingdom , prompting a notable shift in hormone trends. Obtaining these medications remains a complex landscape, with public healthcare system approval currently limited and independent providers offering prescriptions at